We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
+$36.4M
Cap. Flow %
10.41%
Top 10 Hldgs %
7.12%
Holding
478
New
39
Increased
273
Reduced
76
Closed
38

Top Buys

Rank Stock Value
1
OXLC
Oxford Lane Capital
OXLC
+$2.36M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.99M
3
LRCX icon
Lam Research
LRCX
+$1.97M
4
IDXX icon
Idexx Laboratories
IDXX
+$1.96M
5
TKO icon
TKO Group
TKO
+$1.96M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$1.85M
2
KKR icon
KKR & Co
KKR
+$1.62M
3
UAL icon
United Airlines
UAL
+$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

Rank Sector Weight
1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVV icon
351
Ovintiv
OVV
$17.6B
$169K 0.05%
4,182
+48
+1% +$1.96K
REXR icon
352
Rexford Industrial Realty
REXR
$8.13B
$168K 0.05%
4,092
-602
-13% -$23.6K
BRY
353
DELISTED
Berry Corp
BRY
$168K 0.05%
44,499
-7,489
-14% -$24.3K
IVT icon
354
InvenTrust Properties
IVT
$2.56B
$168K 0.05%
5,865
-295
-5% -$8.36K
EOG icon
355
EOG Resources
EOG
$74.6B
$168K 0.05%
1,496
+127
+9% +$15.1K
CRC icon
356
California Resources
CRC
$4.77B
$168K 0.05%
3,154
-527
-14% -$26.4K
LXP icon
357
LXP Industrial Trust
LXP
$3.58B
$167K 0.05%
3,733
-193
-5% -$8.29K
TRNO icon
358
Terreno Realty
TRNO
$7.45B
$167K 0.05%
2,935
-35
-1% -$1.99K
PTEN icon
359
Patterson-UTI
PTEN
$4.19B
$166K 0.05%
32,033
+5,016
+19% +$28.8K
ARCT icon
360
Arcturus Therapeutics
ARCT
$200M
$166K 0.05%
9,002
+1,563
+21% +$25.1K
RCUS icon
361
Arcus Biosciences
RCUS
$3.66B
$165K 0.05%
12,169
+2,112
+21% +$22K
PHVS icon
362
Pharvaris
PHVS
$2.43B
$165K 0.05%
6,604
+1,147
+21% +$25.4K
SNDX icon
363
Syndax Pharmaceuticals
SNDX
$1.82B
$164K 0.05%
10,664
+1,851
+21% +$24.2K
ERAS icon
364
Erasca
ERAS
$6.29B
$162K 0.05%
74,371
+12,912
+21% +$20.5K
SANA icon
365
Sana Biotechnology
SANA
$1B
$159K 0.05%
44,798
+7,777
+21% +$28.1K
ARQT icon
366
Arcutis Biotherapeutics
ARQT
$3.26B
$159K 0.05%
8,429
+1,464
+21% +$23.1K
BEAM icon
367
Beam Therapeutics
BEAM
$2.82B
$158K 0.05%
6,524
+1,132
+21% +$22.5K
IMTX icon
368
Immatics
IMTX
$1.33B
$158K 0.05%
18,532
+3,217
+21% +$19.8K
VRDN icon
369
Viridian Therapeutics
VRDN
$2.61B
$157K 0.04%
7,262
+1,261
+21% +$22.7K
BCAX
370
Bicara Therapeutics
BCAX
$1.82B
$155K 0.04%
9,835
+1,708
+21% +$19.1K
RNAM
371
DELISTED
Avidity Biosciences
RNAM
$154K 0.04%
3,540
+614
+21% +$24.8K
TYRA icon
372
Tyra Biosciences
TYRA
$1.57B
$154K 0.04%
11,015
+1,912
+21% +$21.8K
NAMS icon
373
NewAmsterdam Pharma
NAMS
$3.34B
$154K 0.04%
5,411
+940
+21% +$22.5K
KURA icon
374
Kura Oncology
KURA
$874M
$151K 0.04%
17,085
+2,966
+21% +$21.1K
ANAB icon
375
AnaptysBio
ANAB
$1.64B
$149K 0.04%
4,860
+843
+21% +$19.3K
13 14
15
16 17

Similar funds

WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
RGC
Roberts, Glore & Co Deerfield, Illinois $364M AUM 19.54% 1-Year Est. Return

Virtus Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, Virtus Investment Advisers held 478 positions worth $349M, up 18% from $296M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Virtus Investment Advisers deployed $36.4M of net new capital in Q3 2025, opening 39 new positions and adding to 273 existing holdings. Its largest new stake was Oxford Lane Capital: 129,209 shares worth $2.19M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Incyte, an estimated $1.85M trimmed.

  • Virtus Investment Advisers's largest Q3 2025 buy was Oxford Lane Capital: 129,209 shares worth $2.19M.
  • Virtus Investment Advisers added most to Prospect Capital in Q3 2025, an estimated $697K increase.
  • Virtus Investment Advisers's biggest Q3 2025 reduction was Incyte, cutting an estimated $1.85M.
  • Virtus Investment Advisers fully exited KKR & Co in Q3 2025, selling an estimated $1.62M.
  • Virtus Investment Advisers's ten largest holdings make up 7.1% of its $349M portfolio in Q3 2025.
  • Virtus Investment Advisers opened 39 new positions and closed 38 in Q3 2025.
  • Virtus Investment Advisers's portfolio value rose 18% quarter-over-quarter to $349M.

Based on Virtus Investment Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.